This company has been acquired
EAR Stock Overview
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Eargo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.57 |
| 52 Week High | US$7.52 |
| 52 Week Low | US$1.47 |
| Beta | 1.48 |
| 11 Month Change | -3.75% |
| 3 Month Change | 0.62% |
| 1 Year Change | -64.31% |
| 33 Year Change | -99.80% |
| 5 Year Change | n/a |
| Change since IPO | -99.62% |
Recent News & Updates
Recent updates
Eargo: Straining To Be Heard
Aug 30Eargo jumps 77% following FDA rule on OTC hearing aids
Aug 16Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M
Aug 08Eargo completes $100M senior secured convertible notes issuance
Jul 05Eargo: A Binary Play On Hearing Loss
Dec 30Eargo Is A High Risk 'Option' With High Potential
Oct 08An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued
Jul 10
Eargo: I Am Slowly Starting To Listen
May 06What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?
Jan 16Eargo trades high afte hours on strong Q4 revenue, gross systems shipped
Jan 11Eargo: A Word Of Caution
Dec 15Eargo beats on revenue
Nov 19Shareholder Returns
| EAR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.7% | 0.2% | -1.2% |
| 1Y | -64.3% | 25.5% | 30.6% |
Return vs Industry: EAR underperformed the US Medical Equipment industry which returned 8.3% over the past year.
Return vs Market: EAR underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| EAR volatility | |
|---|---|
| EAR Average Weekly Movement | 2.7% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: EAR has not had significant price volatility in the past 3 months.
Volatility Over Time: EAR's weekly volatility has decreased from 11% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 243 | Bill Brownie | eargo.com |
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel.
Eargo, Inc. Fundamentals Summary
| EAR fundamental statistics | |
|---|---|
| Market cap | US$53.39m |
| Earnings (TTM) | -US$108.17m |
| Revenue (TTM) | US$41.11m |
1.3x
P/S Ratio-0.5x
P/E RatioIs EAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EAR income statement (TTM) | |
|---|---|
| Revenue | US$41.11m |
| Cost of Revenue | US$23.86m |
| Gross Profit | US$17.25m |
| Other Expenses | US$125.42m |
| Earnings | -US$108.17m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.21 |
| Gross Margin | 41.95% |
| Net Profit Margin | -263.14% |
| Debt/Equity Ratio | 0% |
How did EAR perform over the long term?
See historical performance and comparison